Moreover, the functional impact of individual mutations remains largely inferred rather than experimentally validated; future studies integrating in vitro and in vivo models, as well as single-cell and spatial profiling, will be essential to dissect how specific JAK-STAT alterations reshape tumor-immune interactions across ancestries and treatment contexts. This evidence concerns the gene SOAT1 and neoplasm.